Latest AI and machine learning research in flu & uri for healthcare professionals.
Self-assembling protein nanoparticles are being increasingly utilized in the design of next-generati...
Viral infections pose significant global health challenges, underscoring the urgent need for improve...
Hepatitis B virus (HBV) infection causes approximately one million deaths annually and remains a maj...
Influenza A Virus (IAV) poses a persistent threat to global public health due to its broad host adap...
T-cell immunogenicity, the ability of peptide fragments to elicit T-cell responses, is a critical de...
Targeted PCR diagnosis of RNA viruses is sequence dependent, meaning that the accuracy of the assay ...
Extracellular vesicles (EVs) are lipid-delineated nanoparticles that are produced by most cell types...
Messenger RNA (mRNA) therapeutics show immense promise, but their efficacy is limited by suboptimal ...
Avian influenza remains a serious risk to human health via zoonotic transmission, as well as a feasi...
Understanding the spatiotemporal dynamics of T-cell clones is a critical challenge in immunology and...
Seasonal influenza viruses undergo continuous antigenic drift due to mutations in the hemagglutinin ...
A target-specific bait dispenser is required for oral bait vaccination of the endangered Tasmanian d...
While neutralizing ability has traditionally been considered the most important antibody function, a...
Post-Acute Infection Syndromes (PAIS) are medical conditions that persist following acute infections...
Designing effective vaccination strategies against genetically diverse viruses, such as HIV or influ...
SARS-CoV-2 continues to spread over the world steadily as opposed to many earlier estimations that i...
This work introduces a modular, open-source computational pipeline for glioblastoma (GBM) vaccine de...
This work introduces a modular, open-source computational pipeline for glioblastoma (GBM) vaccine de...
Congenital heart disease (CHD), the most common human birth defect, often results from disruptions i...
The selection of an effective adjuvant is a critical bottleneck in vaccine development, particularly...
Tuberculosis claims around 1.5 million lives annually. The M72/AS01E vaccine candidate is an innovat...